$720 million buys a sector
In three months, two corporate buyers have spent $720 million reshaping who owns your doctor. US private equity firm TPG closed a deal in March 2026 to buy Tamaki Health for a reported $450 million, picking up 51 GP and urgent care clinics and more than 230,000 enrolled patients. Then Tend Health agreed to buy The Doctors, Green Cross Health’s medical division, for $270 million, adding 65 clinics and over 400,000 patients.
Put together, the two buyers are poised to control more than 15% of New Zealand general practice. For a sector traditionally run by doctor-owned partnerships, that is a step-change. This is no longer just a health story. It is a capital allocation story playing out in a sector under chronic public funding pressure.
Why the capital is flowing now
General practice has been squeezed for over a decade. Capitation, the per-patient government payment that forms most practices’ revenue, has repeatedly failed to keep pace with cost inflation. GP New Zealand’s December 2024 analysis set a reasonable fee increase of 7.76% for 2024/25, built on input cost growth of 5.88% against a government funding uplift of just 4%. Health sector wages were running hot, with the Labour Cost Index for health care and social assistance showing 6.6% growth against a 4.3% all-sector average.
That margin pressure makes independent ownership harder and consolidation more attractive. It shows in access. As of June 2025, only 71.3% of practices were open to new enrolments, with around half fully open and another 15% open with restrictions.
Yet the underlying economics are not as grim as the squeeze narrative suggests. Ministry of Health figures show average real PHO revenue per enrollee reached $390 in 2023/24, up from $177 in 2010/11. For buyers with scale and back-office leverage, that is a recurring, government-underwritten revenue stream worth owning.
Offshore private equity versus iwi capital
The two deals look similar on a spreadsheet but differ sharply in structure, and that distinction is being lost in much of the coverage. TPG is offshore US private equity with a return mandate. Tend is locally owned and tech-forward, founded by Cecilia Robinson of My Food Bag fame, and backed by a consortium of iwi investors including Ngai Tahu Holdings, Ngati Whatua Orakei, Nati Growth and Ahuahu Group, who will become one of Tend’s largest shareholder groups.
Tend co-chief executive Cecilia Robinson framed the deal as a long-term commitment from New Zealand and iwi to primary care. Post-acquisition, Tend would run over 90 clinics with more than 550,000 enrolled patients, roughly 10% of the enrolled population. The deal still needs shareholder approval at a July 2026 meeting and Commerce Commission clearance, with settlement expected by the end of July.
For Green Cross, the sale is a refocus on its core pharmacy business. The board flagged it would consider retaining proceeds to grow pharmacy or returning capital to shareholders.
The funding redesign favours scale
Here is the part business readers should watch. The government committed $180 million in new general practice funding for 2025/26, the largest uplift in more than a decade, combining a 6.43% capitation increase with a new $60 million contingent capitation stream. That contingent money comes with strings. Practices have to share data and hit performance targets to access it.
Large corporate operators with the technology to capture, report and act on patient data are structurally better placed to win that funding than small independents running on legacy systems. Tend has already moved to become a PHO itself, cutting out the traditional intermediary and accessing public money more directly. The funding architecture is being rebuilt in ways that reward scale, and the capital has arrived to match.
What happens next
The Commerce Commission review is unlikely to block the Tend deal, and consolidation will not stop there. The real question for the next few years is whether shareholder return requirements, particularly under offshore private equity, start shaping clinical decisions, shorter consultations and higher enrolments to maximise capitation. The $1.5 billion in annual primary care funding is now being competed for by operators built to win it. Independents that cannot match the data infrastructure will find the maths increasingly hard to make work.
Sources
- NZ Herald: Tightening corporate control of general practice – who owns your family doctor? (2026-06-26)
- NZ Herald: Tend Health to buy The Doctors clinics from Green Cross Health for $270m (2026-06-02)
- Newswire: Tend Health buys The Doctors for $270 million (2026-06-02)
- NZ Doctor: Tend Health to acquire The Doctors, backed by iwi and local investors
- NZ Doctor: Primary care heading towards supermarket-style duopoly
- BusinessDesk: Green Cross Health NZX announcement
- GPNZ: Annual statement of reasonable GP fee increases 2024 (2024-12)
- Ministry of Health: PHO finances briefing (2025-11)